Nanoscale
Virus Trap Molecule Market - Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026
Advancement into scientific
research has led to the emergence of new technologies that has the potential to
improve drug delivery and effectiveness. With evolution, things are becoming
miniature in size, be it electronic chips, medical devices, or pharmaceutical
drug. However, miniaturization, also referred as nanotechnology, doesn’t
compromise on the product quality and effectiveness. Instead there is improved
quality and features delivered via this technology.
Nanotechnology has a real
potential to revolutionize the medical treatment procedures, and tools making
it more personalized, effective, safe and cheaper. Nanotechnology involves research
of molecules that only 1/100th size of cancer cells but has the potential to
improve the quality of life. Significant progress has already been made in
nanomaterial in terms of developing targeted drug therapies. Some of the
developments in nanotechnology include Quantum dots that can enhance biological
imaging for medical diagnostics, antibody-nanoparticle complex for early
diagnosis of atherosclerosis, use of nanoscale components in molecular imaging,
and regeneration or spurring the growth of nerve cells.
The Virus ‘trap’ Nanoparticle
One of the recent progresses made
in nanotechnology is the technique of combating viruses before they can infect
the host cells. Researchers at Charles Stark Draper Laboratory, the
Massachusetts Institute of Technology, the Univ. of Massachusetts Medical
School, and the Univ. of Santa Barbara have developed nanoparticles that act as
viral ‘traps’ inside the human body. These molecules are surfaced with numerous
carbohydrate molecules that closely resemble those targeted by flu viruses. The
flu viruses bind to these nanotraps instead of host cell and are eliminated
from the body through mucus.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/44
The nanoscale viral trap molecule
technology can also be applicable in diagnosing a viral disease. An innovative
tunable device selectively traps viruses detecting them with 100 times better
sensitivity than the current available techniques. Researchers at the
Pennsylvania State University developed this tool that can trap virus and
remove majority of the host contaminants.
The Technology is Under Research
The nanoparticle molecule is
composed of compounds found naturally in the human body. Hence, it is safe as
an inhalant, intravenous treatment, or topical solution, and inexpensive to
manufacture. Extensive benefits of this technology imply a very high commercial
potential in the treatment of viral infections.
Moreover, this technology has shown to be effective in mice. Further
research in this may lead to use it against HIV virus, Herpes Simplex Virus
(HSV), and Respiratory Syncytial Virus (RSV), as well as bacteria and toxins.
With increasing resistance to anti-viral drugs, need for novel therapies are
realized. This will further help boost the demand for nanoscale virus trap
molecules in the treatment of viral diseases.
However, there are more alternate
therapies under research which can compete with the viral trap molecule
business. Double-stranded RNA Activated Caspase Oligomerizer (DRACO) is a
nanoparticle based drug under research which is designed to detect virally
infected cells and eradicate only those cells from the body. Few in-vivo and
in-vitro trials have proven this drug to be very effective against different
viral strains. The researchers at Charles Stark Draper Laboratory believe that
this drug will be ready for clinical trials in next three to eight years.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/nanoscale-virus-trap-molecule-market-44
Conclusion
The viral trap molecule is poised
to make contributions far beyond the therapies and tools that have been
explored so far. Adequate funding to this research will continue to drive the
efforts in commercializing this technology.
Key Developments
Increasing research and
development activities related to nanoscale virus trap molecule technology is
expected to boost the market growth. For instance, in January 2019, researchers
from Purdue University reported that heparan sulfate, a molecule used by Ross
River virus (RRV) to help them attach to cells can prevent the virus from
escaping, in the journal Virology.
In January 2018, researchers at
the University of Turin evaluated the use of cyclodextrin-based nanosponges as
vehicles for antiviral drugs.
In October 2018, researchers from
Far Eastern Federal University, the Russian Academy of Sciences, and Swinburne
University of Technology developed a technology for trapping and chemical analysis
of organic and non-organic molecules at ultra-low concentrations.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/44
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment